News Release
News Release
October 5,2018
Announcement of Fund Raising through Third Party Allocation of New Shares [PDF file]
September 20,2018
June 5,2018
Submission of a Phase II Clinical Trial Plan for Functional Peptide SR-0379 [PDF file]
May 7,2018
Announcing Acceptance into the AMED Grant Program [PDF file]
April 9,2018
Announce of Conclusion of Option Agreement with Sumitomo Dainippon Pharma [PDF file]
September 16,2016
February 12,2016
Antibody-inducing Peptide Alliance Between MEDIPAL and FunPep [PDF file]
October 29,2015